New Paradigms in the Treatment of Non-Small-Cell Lung Cancer, Head & Neck and Thyroid Cancers
This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.
For more information visit: www.cancernetus.com
This activity is supported by an independent education grant from Lilly USA, LLC Boehringer Ingelheim Pharmaceuticalas, Inc. Exelixis, Inc., and Novartis Pharmaceuticals Corporation.
Scroll to the Bottom of this Information to Begin this Course
Release date: November 18, 2015
Valid through: November 18, 2016
Topic: NSCLC, Head & Neck and Thyroid Cancer
Estimated Time to Complete Activity: 1.0 hour (60 min)
This symposium is directed primarily to hematologists/oncologists, radiation oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in lung cancer, head & neck cancer and thyroid cancer. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.
Statement of Need/Program Overview
This symposium is intended to improve care of patients with lung cancer, head & neck cancer and thyroid cancer by accelerating adoption of new guidelines and evidence-based practice change. The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty.
- Evaluate the emerging treatments options in the management of radioactive iodine-resistant differentiated thyroid cancer
- Interpret and apply data on multi-targeted tyrosine kinase inhibitors from clinical trials and translation into clinical practice for medullary and anaplastic thyroid cancer
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Steven I. Sherman, MD
Naguib Samaan Distinguished Professor in Endocrinology,
Department of Endocrine Neoplasia and Hormonal Disorders,
Division of Internal Medicine,
The University of Texas MD Anderson Cancer Center,
Maria Cabanillas, MD
Associate Professor and Faculty Director of Clinical Research,
Department of Endocrine Neoplasia & Hormonal Disorders,
The University of Texas MD Anderson Cancer Center,
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet. The A. Webb Roberts Center for CME of Baylor Health Care System is accredited by the ACCME to provide continuing medical education for physicians.
The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the webcast.
Disclosures of Conflicts of Interest
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Consultant: Exelixis, Eisai, Bayer
- Advisory Board: : Eisai, Exelixis, Onyx/Bayer
- Research Support: : Roche/Genentech
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Consultant: Synta, Biodesix, AVEO, Eisai, Abbvie, Lilly USA, LLC
- Clinical Studies: Genentech, Synta, Astex, EMD/Serono
- No relevant financial relationships
All other individuals in a position to control content have no relevant financial relationships to disclose.
A. Webb Roberts Center for CME of Baylor Health Care System observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support. To contact CME Provider, call 214-820-2317.
Course Viewing Requirements
Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this webcast. During the period November 18, 2015 through November 18, 2016, participants must read all of the material and study the educational webcast.
Letter of Credit & Transcripts
After submitting the webcast evaluation, you may access your letter of credit by selecting "Your Certificates" on the left navigation bar.
Select "Credit" to view letters of credit onscreen and print from your browser. You may print the letter of credit, but you may not alter the letter of credit.
Your credits will be tallied and may be viewed by selecting "View your transcripts" in the "Your Account" area.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.